STOCKHOLM, Jan. 29, 2021 /PRNewswire/ -- During
January 2021, the registered number
of shares and votes in Moberg Pharma AB (OMX: MOB) ("Moberg Pharma"
or the "Company") has increased due to the completion of the
previously announced rights issue, and the final conversion of
convertible notes issued pursuant to the financing agreement
entered into between the Company and Nice & Green S.A. on
March 23rd, 2020.
During January 2021, the total
number of shares and votes in the Company has increased by
24,181,899, corresponding to 24,181,899 votes, whereof 23,175,576
common shares through the registration of the rights issue and
1,006,323 shares as a result of the board of directors' resolution
to approve Nice & Green S.A.'s request to convert convertible
notes into common shares of the Company. As a result of the
completion of the rights issue, the financing agreement regarding
convertible notes is terminated.
At the date of this press release, the total number of shares in
Moberg Pharma amounts to 44,601,425. All shares are common shares.
The total number of votes are 44,601,425. At the date of this press
release, the Company holds 554,746 own common shares.
For additional information, please contact:
Anna Ljung, CEO, telephone:
+46 707 66 60 30, e-mail: anna.ljung@mobergpharma.se
Mark Beveridge, VP Finance,
telephone: +46 76 - 805 82 88, e-mail:
mark.beveridge@mobergpharma.se
About this information
The above information has been made public in accordance with
the Swedish Financial Instruments Trading Act. The information was
released for public distribution on January
29th 2021 at 8:00 am
CET.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/moberg-pharma/r/new-number-of-shares-and-votes-in-moberg-pharma-ab--publ-,c3275875
The following files are available for download:
https://mb.cision.com/Main/1662/3275875/1365051.pdf
|
New number of shares
and votes in Moberg Pharma AB (publ)
|
View original
content:http://www.prnewswire.com/news-releases/new-number-of-shares-and-votes-in-moberg-pharma-ab-publ-301217911.html
SOURCE Moberg Pharma